GUJPHARM

GUJPHARM

Sunday, July 10, 2011

PhD / MPharm/ MBA(Pharma) in Gujarat

A)PG Courses after B.Pharm
Many Institute got approvalof new courses of M.Pharm as below specialization
a)AICTE approved M.Pharm Courses(Specialization)in GUJARAT http://www.gtu.ac.in
1) Pharm. Chemistry
2) Pharmaceutical Tech. and Pharmaceutics
3) Pharmacology
4) Quality Assurance
5) Pharmacognosy
6) Clinical Pharmacy
7) Pharmaceutical Analysis-I
8) Pharmaceutics
9) Pharmaceutical Quality Assurance
10) Pharmaceutical Technology
11) Pharmacology & Toxicology

b)New AICTE approved M.Pharm Course in GUJARAT
Pharma Management and Regulatory Affairs (18) seats at KBIPER, Gandhinagar 382023

c)Management degree after B.Pharm in Gujarat
MBA(Pharma) UGC approved at Kadi Sarva Vishwavidyalaya, Gandhinagar (http://ksvuniversity.org.in)

B)PhD Guide List in Pharmacy
http://www.gtu.ac.in/PHD/SupervisorApril2011(Pharmacy).pdf
http://ksvuniversity.org.in/docs/Phdguidelist.pdf
Other Universities: Nirma University, Ganpat University, Sumandeep etc

Saturday, June 11, 2011

NEWSLETTER

NEWS
Code of Marketing Practice for Indian Pharmaceutical Industry
www.pharmaceuticals.gov.in/uniformcode.pdf


ADMISSIONS
PHARM. D
KADI SARVA VISHWAVIDYALAYA
http://ksvuniversity.org.in/docs/admissionform.pdf

2011 M. Pharm. / Ph.D. (Full-Time and External)
Nirma University is a statutory University recognized by the UGC under section 2(f) and the Institute of Pharmacy is one of its constituent institutions. The institute invites applications for admission to the following programmes.
1. M. Pharm.
2. Ph.D. (Full-time and External)
Application Forms along with prospectus for admission can be downloaded from our
website: www.nirmauni.ac.in

EVENTS
Three days "Workshop on Designing Clinical Trial Protocol" at KBIPER, Gandhinagar
ONLY SELECTED REGISTRATION contact shrikalp@gmail.com

Friday, June 10, 2011

NEWSLETTER WILL BE SOON

GUJPHARM NEWSLETTER WILL BE SOON update


Add / submit information for GUJPHARM NEWS LETTER by email shrikalp@gmail.com


ADMISSION: M.Pharm/ PhD

EVENTS: Seminar/Conference future events

SUGGESTIONS:

NEWS:

Tuesday, June 22, 2010

KBIPER

Friday, April 2, 2010

Refresher Course for Registered Pharmacists GSPC

Refresher Course for Registered Pharmacists
Sponsored by GSPC – Gujarat State Pharmacy Council

10th and 11th April'2010 @ Shantilal Shah Pharmacy College, Bhavnagar
Bhavnagar University is going to organize "Two Days State Level Refresher Course for Registered Pharmacists" sponsored by Gujarat State Pharmacy Council. The scheduled dates are 10th and 11th April'2010. Venue will be University Court Hall, Bhavnagar University Campus, Bhavnagar. All the registered pharmacists are requested to participate. The registration shall be done on "First Come First Serve" basis. For more details contact Mr.Manish Upadhyay, lecturer (Mob. 9924343600) or Mr. Himal Pandya,Principal Incharge (Mob. 98790 49553). S.S.Pharmacy College, Bhavnagar University

26th and 27th June '2010 @ Maliba Pharmacy College, Bardoli

Maliba Pharmacy College is organizing "Two Days State Level Refresher Course for Registered Pharmacists" sponsored by Gujarat State Pharmacy Council. The scheduled dates are 26th and 27th June '2010. All the registered pharmacists are requested to participate. The registration shall be done on "First Come First Serve" basis. For more details contact Mr. Ketan Ranch lecturer (Mob. 9925475599) or Mr.Sandesh Lodha(Mob. 9998944423.
Dr Dinesh Shah, Principal, Maliba Pharmacy College, Gopal VidhyanagarBardoli-Mahuva Road Dist Surat 394350

9th and 10th July 2010 @ K. B. Institute of Pharmaceutical Education and Research Gandhinagar

Organized by: KBIPER K. B. Institute of Pharmaceutical Education and Research, Sector 23, Nr. Gh/6 Circle, Gandhinagar 382023. Tel: 079 23245270 /23249069 Dr Shrikalp Deshpande, and Mr Divyesh Shastri, KBIPER, Sector 23, Gandhinagar 382023.

Sunday, November 8, 2009

GUJPHARM IIPC - GUJARAT PHARMA INSTITUTE INDUSTRY PARTNERSHIP CELL

GUJPHARM


· Projects are invited from Pharma Academic and Research Centers.
· As Individual send your interest as I – Individuals / M - Team-group member / V-volunteers.
· Pharma companies needed for any services as a part of Gujpharm IIPC can be done are invited.
· For any further information and suggestions contact Dr Shrikalp Deshpande, 9427774447 shrikalp@gmail.com




GUJPHARM IIPC - GUJARAT PHARMA INSTITUTE INDUSTRY PARTNERSHIP CELL

Name of the Institute and contact persons



Code Title

A Animal (Pre-clinical)
A.1 Toxicity Studies
A.2 Evaluation Studies
A.3 Specific studies
A.4 Others

B Biotechnology
B.1 Non regulatory
B.2 Regulatory
B.3 others

C Clinical Research
C.1 BA
C.2 BE
C.3 Clinical Trials
C.4 PMS
C.5 Others

D Formulation & Development
D.1 Formulation problem
D.2 Stability studies
D.3 Platform Technology
D.4 Others

E Educational Certificate Courses
E.1 Regulatory Affairs
E.2 Biostatistics
E.3 GCP
E.4 GMP
E.5 GLP
E.6 IPR
E.7 Marketing

F Project Reports

G Regulatory Affairs & Documentation
G.1 Indian Regulatory
G.2 Documentation Preparation (CTD,
G.3 Others

H Herbal drugs
H.1 Formulation development & manufacturing
H.2 Formulation queries
H.3 Evaluation of drugs with marketed formulation
H.4 Others

I Marketing Research and Survey
I.1 Marketing projects
I.2 Marketing field survey
I.3 Special survey with Physicians, Experts…
I.4 Pharma segment survey in Gujarat

J Analytical Research
J.1Estimation method
J.2 Analytical method development (UV-Visible, HPLC /LC-MS etc )
J.3 Validation methods and study
J.4 others

K Event management
K.1 Seminar
K.2 Workshop
K.3 Symposium
K.4Conference
K.5 Others

Note:
Ethics Committee Permission
Animal Ethics Committee from IAEC
Clinical Ethics Committee from IRB / IEC
Many projects can be plan at Academic (Institute), Research Centre and Pharma Industry.
IAEC (CPCSEA) permission can be done at Institute having facilities of conducting research projects and CPCSEA registered animal house.
IRB/IEC approval is applicable for Clinical Research.

Tuesday, April 21, 2009

4th News Letter

NEWS

ACADEMICS

KSV’s – K. B. Institute of Pharmaceutical Education and Research
Workshop on “Quality and Relevance in Research” was organized at KSV- Kadi Sarva Vishvavidyalaya on 14th April 2009 for Pharmacy and Biotechnology faculty and PhD students. The Key note address was given by Prof. R. K. Goyal, Vice Chancellor, M S University, Baroda. Other speakers were Dr Bhatt, Sun Agrigenetics P. Ltd., Baroda and Dr M. C. Sharma, Director, Biotecnology Dept. KSV

Anand Pharmacy College, Anand
Ms. Avani P.Shah student of M.Pharm pharmacology - Anand Pharmacy College, Anand has been the 1st student of Gujarat to be conferred with 54th Indian Pharmaceutical Congress(IPC) Award as " Outstanding Student of the year 2007-08 given by IPA- Indian Pharmaceutical Association.

Saurashtra University, Rajkot
The MOU between Saurashtra University and New Mexico University Workshop was organized by Saurashtra University, Rajkot on 11th April, 2009. On this occasion, a one day Workshop on RECENT ADVANCES IN GLOBAL HEALTHRESEARCH AND TELEMEDICINE was jointly organizing by Department Pharmaceutical Sciences and Faculty of Medicine of Saurashtra University, Rajkot (Gujarat). Dr. Pratap C. Shah, Urologist, and Faculty, Global Health, Univ. of New Mexico. Dr. Kamleshbhai Joshipura, Hon.Vice-Chancellor, Saurashtra University preside the function. Dr. D. K. shah, Dean, Faculty of Medicine and Prof. (Dr.) Navin Sheth, Head, Department of Pharma. Sciences welcome all the dignitaries and guests.Dr. Ravi Durvasula, Associate Professor and Chief of Medicine at the New Mexico Health Care System and Director, Global Health, Univ. of New Mexico., U.S.A.Dr. Dale Alverson, President of American Telemedicine Associaton, Professor of pediatrics at the Univ. of New Mexico, U.S.A. Dr. D. J. Perkins, director, Global and Geographic Medicine Program at Univ.of New Mexico, U.S.A. More than 100 delegates as dignitaries from health, research scientists, academicians from reputed medical and pharmacy colleges and medical personnel grace the occasion with their esteemed presence.

PHARMA INDUSTRY
The Economics Times April 16, 2009
Pharma cos have it tough this quarter
WEAK OVERSEAS DEMAND, HIGH INTEREST COSTS LIKELY TO PULL PROFITS DOWN
THE pharma sector is expected to be an underperformer during the fourth quarter of FY09. The growth in revenues and earnings is likely to be lower than that observed in the previous three quarters of the fiscal. High base-year effect for some companies, delay in US FDA approvals, lower demand in the exports market, increase in the receivable days and high interest cost for companies in debt are likely to adversely affect companies’ profits. Some respite is likely to come from the rupee depreciation of around 5% and easing off of raw material costs. With AS11 no longer mandatory, drug makers are not expected to report MTM loss on their foreign exchange borrowings. Average estimates of leading seven pharma companies by ETIG and five brokerages indicate 43% drop in net profits during the quarter ended March 2009, against the corresponding quarter in the previous year. Revenues are expected to increase by a modest 6% y-o-y. The net profit margin is estimated to drop by 957 bps to 11.4% for the quarter ended March 2009. While Ranbaxy is estimated to report a loss due to its ongoing issues with US FDA, companies like Sun Pharma, Piramal Healthcare and Dr Reddy’s are likely to report a significant drop in their profits. In absence of exclusivities that were enjoyed during the fourth quarter last year, Sun Pharma is likely to report a drop in revenues and earnings. DRL’s profits are likely to be dented on account of writeoffs by its German subsidiary. Piramal Healthcare is expected to report a drop in profit due to one-time writeback of NCE research expenses in Q4 FY08. While the pricing pressures in overseas markets of Europe and North America continued, the quarter also witnessed increase in US FDA’s scrutiny of the regulatory compliance practices followed by domestic pharma companies. Many Indian companies are now facing increased inspection and enquiries by the US healthcare agency.

The Economics Times April 15, 2009
Breach of clinical trial norms may invite 10 years in jail
Govt May Amend Law; Violation May Also Attract Cancellation Of Licence
THE government plans to amend the Drugs & Cosmetics Act to slap up to 10 years’ imprisonment and cancellation of licence for violating norms for testing drugs on humans in India, a government official said. “The new set of guidelines would ensure that those who do not follow the norms approved by the Drug Controller General of India (DCGI) for conducting clinical trials on humans are brought to book and punished,” Dr Vishwa Mohan Katoch, secretary in the department of health research and director general of the Indian Council of Medical Research (ICMR), told ET. The move comes in the wake of the drug regulator’s failure to take action against several companies even after finding gaps in their clinical trials during audits, due to the absence of legal provisions. The proposed guidelines for conducting clinical trials of experimental drugs in India, framed by ICMR, have been approved by the ministries of law and health. The move is intended to improve the country’s image in this area, which has been sullied by some cases of alleged unethical and sub-standard practices. India has become a hub for clinical trials of drugs with a clinical research market estimated at $389 million, which is forecast to touch $1 billion by 2010. Having a tough, credible regulatory set-up is crucial to enable the growth of this industry while protecting the rights of Indians who volunteer to become test subjects. India does not allow Phase 1 trials, or initial experimentation on human subjects after a drug is found effective on laboratory animals, for molecules developed abroad. This prevents Indians from being the initial guinea pigs for foreign drug companies. Recently, DCGI conducted the first audit of a clinical trial for Wyeth’s advanced pneumonia vaccine after an infant’s death was reported during the trial last October. It turned out that the child had been administered not the experimental vaccine but an already licensed, widely distributed vaccine in the double-blind study. Health ministry wants separate provision to check offenders BUT the child should not have been enrolled in the study at all on account of a cardiac condition it suffered from, the drug regulator’s audit had found. However, in the absence of legal provisions, the regulator is still weighing future action in this case. In another incident last year, 49 children died during clinical trials at the country’s premier medical institution All India Institute of Medical Sciences. Later, a high-level committee found that none of the drugs had been tested on healthy children and rather they were suffering from highrisk illnesses and were also in a serious condition. “Even as the DCGI prescribes certain protocols while allowing any company to conduct clinical trial, it does not have statutory powers to punish companies that do not follow these guidelines or violate any norms,” said a health ministry official who asked not to be named. The most important part of these guidelines is that the person undergoing the experiment is informed about the risks involved while giving consent. The norms also specify the eligibility of a human subject to participate in the experiment. The health ministry now plans to bring in a separate provision in the Drugs and Cosmetics Act to deal with offenders to check unethical human experiments in India. So far, India has established only voluntary guidelines for testing experimental drugs on humans. Drugmakers as well as companies which do such experiments for a fee may choose to register themselves with the ICMR or with the World Health Organisation (WHO). But this is not yet mandatory. According to critics like All India People’s Science Network secretary Amit Sengupta, the government move is too little too late. The government relaxed earlier laws to allow clinical trials of drugs developed in foreign countries and now Indians are treated as guinea pigs to promote clinical research organisations who are sub-contractors of foreign multinationals, he said. “In this background, if the government wants to safeguard public interest, this is bolting the door after the horse has run away,” Mr Sengupta said. Experts also say very few pathology laboratories in India follow good laboratory practices and the data they generate are often fake. There is also a lack of adequate infrastructure and expertise for conducting clinical trial.

Tuesday, July 22, 2008

NEWSLETTER 3

http://gujpharm.blogspot.com/
Important Notice:
Ø All members of Gujpharm have to read and agree New Terms and Conditions http://tech.groups.yahoo.com/group/gujpharm/?v=1&t=search&ch=web&pub=groups&sec=group&slk=1 Members willing to unsubscribe can visit gujpharm-unsubscribe@yahoogroups.com
Ø After thinking at various level GUJPHARM plans to make NGO / Co-operative trust of active members. We wish to have CORE Group and INVITE for honorarium active members to join the Executive.
Ø Objective: Information and Educational NEWS about Gujarat Pharma in Industries, CROs, R&D, Education etc

Congratulations!!!!
Ø Dr R. Balaraman Professor and HOD –Pharmacology, Dept. of Pharmacy, M S University, Baroda for Dr.(Mrs) Lalitha Kameswaran Memorial Oration at SRIPS, Pondicherry on 21st July 2008.
Ø Dr C. N. Patel, Principal, Shri Sarvajanik Pharmacy College, Mehsana and Vice President, APTI-Gujarat State (2005-2008) for being President, APTI-Gujarat State (2008-2011)
Ø Dr Mandev Patel, has join as Principal of K. B. Raval College of Pharmacy, Kalol.

Ø Shrikalp Deshpande, Professor, KBIPER, Gandhinagar for being Vice President, APTI-Gujarat State (2008-2011)

Events of 2008
Ø 60th IPC- Indian Pharmaceutical Congress on 12th -14th December, 2008 at Netaji Subhas Institute of technology, Dwarka, New Delhi-110078 by Indian Pharmacy Graduate’s Association. http://www.nsit.ac.in/
Ø 41st ACIPS- Annual Conference of Indian Pharmacological Society on 18th -20th December, 2008 at Department of Pharmacology, All India Institute of Medical Sciences, New Delhi, INDIA. http://www.ips-aiims.com/
Ø AICTE Sponsored Two Days National Seminar on “Mcroparticulate Systems: A potential Approach to Drug Deliery” on 12th -13th September 2008 Organized by Ganpat University , S K Patel College of Pharmaceutical Education and Research, Kherva. skpcper@ganpatuniversity.ac.in

Research:
Human blood vessels grown in mice Scientists have used human cells to grow new blood vessels in a mouse for the first time, a US journal reports. http://news.bbc.co.uk/1/hi/health/7514317.stm

Websites
http://www.pci.nic.in/
PCI- Pharmacy Council of India has announced Pharm.D. Regulations 2008. Regulations framed under section 10 of the Pharmacy Act, 1948 (8 of 1948). (As approved by the Government of India, Ministry of Health vide, letter No.V.13013/1/2007-PMS, dated the 13th March, 2008 and notified by the Pharmacy Council of India). Pharm.D: The duration of the course shall be six academic years (five years of study and one year of internship or residency)

Moderator for Gujpharm
Dr Shrikalp Deshpande, Gandhinagar. 9427774447 drssdeshpande@yahoo.com

Saturday, July 5, 2008

NEWSLETTER 2

http://gujpharm.blogspot.com/

News of the Month
GUJPHARM suggests and offers PGCC - Post Graduate Certificate Courses in Clinical Research, Regulatory Affairs, QA-QC, IPR, Marketing etc as Short Term Training Courses in specialized subjects.
Basic objective of such Courses is to make the Pharmacy Institute itself self sufficient and give the training and exposure to the students as per the need of Pharma Industries, CROs and R&D. Its my personal opinion and suggestion that Many Pharmacy Institutes of Gujarat can start PGCCs by their own and Pharmacy students did not require to waste time of 1-2 years and 1-3 lakhs of rupees for any other Institute or Center.
Additional to the basic degree of B. Pharm / M. Pharm, students can get certificate in the field of their interest and wish to join for profession. Add on courses can also help the student for Interview and at Job. Programme can be planned for 15 days / 2 months weekend / Special Batch. Basic fundamental of the syllabus for any Certificate is already in the B. Pharm / M. Pharm Syllabus Pharmacy Institute can add the update /recent part in the syllabus as per the need.

Retirement from LMCP but not from Profession
Ø Prof. D. D. Santani is retired as HOD and Professor Pharmacology Dept, L M College of Pharmacy, Ahmedabad on 14th June 2008. He has started the Course of M.Pharm (Clinical Pharmacy) at ROFEL Pharmacy College, Vapi. Prof. D D Santani may continue at Vapi and new mission in near future. Best Wishes to Prof. D. D. Santani
New Place
Ø Dr A. K Seth will join as Principal of Pharmacy College, Sumandeep Vidhyapeth University, Pipariya, Dist. Vadodara

Admission
Ø Ph D and M. Pharm (Pharmacology, Pharmacognosy, Pharmaceutics & QA). and MBA (Pharmaceutical Management). K B Institute of Pharmaceutical Education and Research, Sector 23,Gandhinagar 382023. www.kbiper.org

Websites
Central Drugs Standard Control Organization, Ministry of Health and Family Welfare, Government of India http://www.cdsco.nic.in/
FDCA - Food and Drugs Control Administration, Gujarat State http://gujhealth.gov.in/FDCA/index.htm

Mirror
After giving various level of interviews for the post few Pharma Industries are taking Bond from the selected candidates for 2/3 years for 2/3 lakhs of rupees. They also keep the original Mark sheets and other documents with them. It is not the right profession and ethics.

Moderator for Gujpharm
Dr Shrikalp Deshpande, Gandhinagar. 9427774447 drssdeshpande@yahoo.com

Sunday, June 8, 2008

Newsletter 1

Gujpharm Newsletter
News of the Month
Prof. R K Goyal has joined as Vice Chancellor of M S University, Baroda.
New Place
Dr K R Vadalia has joined as Principal of H N Shukla College of Pharmacy, Rajkot.
Mr Ankit Ajmera has joined as Assistant Professor at K B Raval College of Pharmacy, Kalol.
Admission Open
M.Pharm in Pharmaceutics, Pharmacognosy, Biotechnology at Pharmaceutical Sciences,
Last Date of Submission of completely filled form 30th June 2008. SAURASHTRA UNIVERSITY, Department of Pharmaceutical Sciences, Rajkot – 360 005
Phone: Office: + 91-281-2578501 to 10 – Ext. 493/492, Phone & Fax: 0281 - 2585083
e-mail: headpharmacy@indiatimes.com, Website: www.saurashtrauniversity.edu

M.Pharm in Pharmaceutical Technology and Biopharmaceutics, Pharmaceutical Analysis, .Pharmacology, Medicinal Chemistry, Phytopharmaceuticals and Natural Products Last date for Receiving Application Forms - 25th June NIRMA University, Ahmedabad http://www.nirmauni.ac.in/ip/application_forms.asp
Few other Institutes for M.Pharm admission form will be available from 15th June 2008
Faculty Recruitment
Institute of Pharmacy, Nirma University, Ahmedabad http://download.nirmauni.ac.in/recruitment/
Important Website
Gujarat State Pharmacy Council http://www.pharmacycouncil.gujarat.gov.in
Forth Coming Events and Last Date
Indian Pharmaceutical Association – IPA Gujarat State Branch Election of EC for the term 2008-2010 last date for filling nomination 12th June 2008

Tuesday, May 13, 2008